Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review

Cytomegalovirus (CMV) is a leading opportunistic infection in immune compromised patients, including allogeneic hematopoietic stem cell (HSCT) or solid organ transplant (SOT) recipients, where primary infection or reactivation is associated with increased morbidity and mortality. Antiviral drugs are...

Descripción completa

Detalles Bibliográficos
Autores principales: El Helou, Guy, Razonable, Raymund R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556539/
https://www.ncbi.nlm.nih.gov/pubmed/31239725
http://dx.doi.org/10.2147/IDR.S180908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556539/
https://www.ncbi.nlm.nih.gov/pubmed/31239725
http://dx.doi.org/10.2147/IDR.S180908

Ejemplares similares